NONA
WST icon

Ninety One North America’s West Pharmaceutical WST Stock Holding History

Ninety One North America’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,862
Closed -$3.91M – 86
2024
Q2 		$3.91M Sell
11,862
-772
-6% -$273K 0.2% 59
2024
Q1 		$5M Buy
12,634
+914
+8% +$338K 0.24% 56
2023
Q4 		$4.13M Buy
11,720
+2,368
+25% +$838K 0.2% 59
2023
Q3 		$3.51M Sell
9,352
-26
-0.3% -$10.1K 0.17% 62
2023
Q2 		$3.59M Buy
9,378
+178
+2% +$63.6K 0.15% 81
2023
Q1 		$3.19M Buy
+9,200
New +$2.69M 0.14% 79

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ninety One North America's WST Position: Q3 2024 in Review

Ninety One North America sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 11,862 shares — an estimated $3.91M sold.

Ninety One North America first reported a position in WST in Q1 2023 and held it in 6 quarters. The position peaked at $5M in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Ninety One North America reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Ninety One North America sold 11,862 West Pharmaceutical shares in Q3 2024, an estimated $3.91M.
  • Ninety One North America first reported a position in West Pharmaceutical in Q1 2023 and held it in 6 quarters.
  • Ninety One North America's West Pharmaceutical position peaked at $5M in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Ninety One North America's 13F filing for Q3 2024, filed 12 Nov 2024.